Increased outsourcing among U.S. pharma and biotech firms is fueling significant expansion in the small molecule CDMO sector, with investments in capacity, compliance, and advanced manufacturing capabilities.

Chinese producers are dramatically cutting prices for pharmaceutical ingredients, disrupting Asia's drug manufacturing landscape and challenging supply chains worldwide.

South Korea’s HIRA debuts a unified, cloud-based system for real-time disclosure of all financial transactions between pharma/device companies and healthcare professionals.

Otsuka Pharmaceutical's donidalorsen, a hereditary angioedema prevention drug licensed from Ionis Pharmaceuticals, has received a positive opinion from the EMA's Committee for Medicinal Products for Human Use, advancing its approval prospects in Europe.

Merck announced today that WINREVAIR™ (sotatercept-csrk) met the primary endpoint in its Phase 2 CADENCE study for pulmonary hypertension due to heart failure with preserved ejection fraction.

South Korean biotech firms ABL Bio, Alteogen, and LegoChem Biosciences secure multibillion-dollar licensing agreements with Eli Lilly, GlaxoSmithKline, AstraZeneca, Daiichi Sankyo, and Ono Pharmaceutical, highlighting the rising global competitiveness of Korea's drug-development platforms.

The European Medicines Agency has published draft regulatory guidance on quality aspects for bacteriophage-based pharmaceuticals, setting new standards for the development and manufacture of antimicrobial drugs in Europe.

Sandoz has launched TYRUKO, the nation’s first and only biosimilar to natalizumab, for multiple sclerosis, advancing biologics competition and patient access in the US pharmaceutical market.

China finalizes the first-ever coordinated negotiations for both National Reimbursement Drug List and Commercial Health Insurance Innovative Drug List, opening major access pathways for innovative and high-cost pharmaceuticals.

Bavarian Nordic wins a four-year joint procurement contract with the European Commission, supplying up to 8 million smallpox/mpox vaccine doses across Europe.